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The technological evolution of computed tomography (CT) in the last decade has placed CT coronary angiography (CTCA) in the
spotlight of imaging modalities available to evaluate patients with coronary artery disease. Widespread utilisation of CTCA has generated
concern from the medical community regarding potential health issues related to the significant radiation exposure associated with this
method, and several modifications of the CTCA technique have been proposed to reduce the radiation exposure without affecting the
diagnostic image quality. This review will discuss a practical approach to performing CTCA to ensure that the radiation dose is minimized
while maintaining diagnostic image quality.Re´sume´
L’e´volution technologique de la tomodensitome´trie au cours de la dernie`re de´cennie a projete´ la coronarographie par tomodensitome´trie a`
l’avant-plan des moyens d’imagerie permettant d’e´valuer les patients atteints de coronaropathie. L’utilisation tre`s re´pandue de la coro-
narographie par tomodensitome´trie a suscite´ des inquie´tudes au sein de la collectivite´ me´dicale concernant d’e´ventuels proble`mes de sante´
lie´s a` une importante exposition aux radiations associe´e a` cette me´thode, et plusieurs modifications a` apporter a` la technique de coro-
narographie par tomodensitome´trie ont e´te´ propose´es afin de re´duire l’exposition aux radiations sans compromettre la qualite´ de l’image
servant au diagnostic. Cet article traitera d’une approche pratique pour effectuer des coronarographies par tomodensitome´trie de fac¸on a`
re´duire au minimum la dose de radiation tout en maintenant la qualite´ de l’image servant au diagnostic.
 2010 Canadian Association of Radiologists. All rights reserved.
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raphy (CT) have enabled acquisition of large image data sets,
with unprecedented temporal and spatial resolution, thereby
facilitating noninvasive evaluation of the coronary arteries [1].
The high sensitivity and negative predictive value of CT
coronary angiography (CTCA) for excluding significant
coronary atherosclerosis has led to the recognition of the value
of this procedure in patients with intermediate cardiovascular
risk [2]. However, the prevalence and impact of coronary* Address for correspondence: Felipe S. Torres, MD, Division of Cardio-
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doi:10.1016/j.carj.2009.11.013atherosclerosis on public health, combined with heightened
societal awareness of health issues, has precipitated wide-
spread utilisation of CTCA, which has subsequently generated
concern from the medical community with regard to a potential
increase in the lifetime attributable risk of cancer [3]. Because
the use of ionizing radiation requires adherence to the ALARA
(as low as reasonably achievable) principle, it is important to
ensure that CTCA is performed with optimization of imaging
protocols [4].This review will discuss a practical approach to
performing CTCA to ensure that the radiation dose is mini-
mized while maintaining diagnostic image quality.
Optimization of CTCA
Several factors must be considered to perform an optimal
CTCA, and these can be broadly grouped in 1 of 3 sequentialll rights reserved.
Table 1
Appropriate indications for computed tomographic coronary angiographya
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(3) after image acquisition.Detection of CAD: symptomaticdevaluation of chest pain syndrome
 Intermediate pretest probability of CADStep 1: Patient Preparation  ECG uninterpretable or unable to exercise
Detection of CAD: symptomaticdevaluation of intracardiac structures
 Evaluation of suspected coronary anomalies
Detection of CAD: symptomaticeacute chest pain
 Intermediate pretest probability of CAD
 No ECG changes, and serial enzymes are negative
Detection of CAD with prior test resultsdevaluation of chest pain syndrome
 Uninterpretable or equivocal stress test (exercise, perfusion, or stress
echo)
Structure and functiondmorphology
 Evaluation of coronary arteries in patients with new onset heart failure
to assess etiology
Structure and functiondevaluation of intra- and extracardiac structures
 Evaluation of pulmonary vein anatomy before invasive radiofrequency
ablation for atrial fibrillation
 Noninvasive coronary vein mapping before placement of biventricular
pacemaker
 Noninvasive coronary arterial mapping, including internal mammary
artery before repeated cardiac surgical revascularization
CAD ¼ coronary artery disease; ECG ¼ electrocardiography.
aModified from Ref. 2.Although the specifics of the multidetector CT (MDCT)
unit are important, the most critical factors associated with
achieving optimal diagnostic image quality at the lowest
achievable radiation dose are related to what happens to the
patient before entering the CT suite.
Appropriate Indication
An appropriate indication for CTCA is paramount to limit
unnecessary radiation exposure. Guidelines for appropriate
indications for CTCA, published national and international
recommendations from radiology and cardiology societies,
are available [2,5,6]. CTCA is not indicated as a screening
tool and should not be considered a screening method for
asymptomatic individuals (class III, level of evidence: C) [6].
Appropriate indications for CTCA based on current guide-
lines are summarized in Table 1 [2].
Information
Adequate patient preparation will determine whether a diag-
nostic CTCA study will be achieved at an acceptable radiation
dose, because an inadequate study may lead to repeated exam-
inations and consequently result in a higher total radiation dose.
Patient instructions are an essential part of the process and
should include a detailed explanation of the procedure at the
appropriate level of comprehension and the use of language
translators whenever necessary. A sample instruction leaflet is
attached in Appendix A. The patient should avoid ingestion of
drinks and foods that contain substances that may increase the
basal heart rate, particularly caffeine, at least within 6 hours
before the scan. Caffeine is incorporated into many different
medicines and drinks; the most common are listed in Appendix
B. The patient should be assessed in a quiet area preferably by
a trained and experienced nurse, who should use a calm and
reassuring manner to explain the procedure to the patient,
including the necessity of premedication, the importance of
breath holding, and the use of intravenous contrast media.
Breath-holding Instructions
Patient respiratory or body motion during data acquisition
is not uncommon during CTCA and can render an otherwise
‘‘perfect’’ examination nondiagnostic [7,8]. Therefore, it is
essential to stress the importance of avoiding body motion
and of proper breath holding during the examination. In our
practice, the patient has 2 separate training sessions in
breath-holding maneuvers (each breath-hold exercise is 10
seconds), initially by the cardiac-trained nurse and subse-
quently by the cardiac-trained CT technologist, before per-
forming the examination.
Heart Rate Control: Oral Medication
A slow and regular heart rate is one of the most important
determinants of image quality and radiation dose inCTCA [9]. The gantry rotation speed of modern MDCT units
is 270e350 ms, and, because a minimum of 180 degrees of
scan data is required for image reconstruction, the effective
temporal resolution of single-detector CT systems is
approximately 135e175 ms [1]. The effective temporal
resolution for dual-detector CT systems, 75e83 ms [10,11],
is a significant improvement but remains significantly longer
than cine fluoroscopy. Because coronary arteries and indi-
vidual coronary artery segments exhibit complex motion
with speeds of approximately 20e110 mm/s [12], to achieve
‘‘motionless’’ coronary arteries with current levels of
temporal resolution, the heart needs to be artificially slowed.
The accepted target heart rate for data acquisition during
CTCA for single-detector CT systems is 65 beats per minute
(bpm) or fewer. Therefore, the preferable target heart rate
before entering the CT suite is 60 bpm, because there often
is an increase in the heart rate when the patient lies in the CT
gantry, receives sublingual nitroglycerin, or feels the warmth
associated with injection of intravenous iodinated contrast
media.
The most popular method of controlling the heart rate
during CTCA is to use beta-blockers, preferably a short-
acting agent such as metoprolol [13]. The plasma levels
achieved after an oral dose of metoprolol can be extremely
variable, because metoprolol is metabolized in the liver by
the cytochrome P450 enzyme system and genetic poly-
morphism of drug metabolizing enzymes gives rise to
distinct subgroups in the population that differ in their ability
to perform certain drug biotransformation reactions. [14]. It
is estimated that up to 20% of North Americans are ultra-
rapid metabolizers, which results in lower plasma levels and
diminished effect on the heart rate [15]. Therefore, the
correct dose to be administered is difficult to predict. In our
practice, we have progressed from using a single oral dose of
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current practice of 75 mg for patients who weigh <65 kg and
150 mg for patients who weigh 65 kg. Although dose
stratification based on body weight is neither ideal nor
rational, based on the pharmacokinetics of metoprolol, this
scheme works well in the majority of patients [7] by ensuring
a sustained sinus bradycardia (<60 bpm). The oral prepa-
ration is given 1 hour before the scan time, and the patient is
transferred into the CT suite, at 45 minutes after metoprolol
administration, where patient setup takes approximately 10e
15 minutes. Alternatively, depending on local circumstances,
patient comprehension, and comorbidities, patients can be
given a prescription to take oral metoprolol 50e100 mg the
night before the procedure and a second dose before the
examination [16].
Intravenous Access
The presence of an adequate and secure intravenous line
is very important to avoid complications and unsuccessful
examinations. An 18-gauge or larger antecubital cannula is
recommended to allow flow rates of 5e6 mL/s, and the right
arm is preferred to avoid streak artifacts from injected
contrast within the left innominate vein, particularly in
patients who are posteleft internal mammary artery graft
bypass surgery and in whom it is important to visualize this
area of anatomy.Step 2: Inside the CT Suite
Coronary Calcium Score
The coronary calcium score (CCS) is a good predictor of
cardiovascular events and adds incremental prognostic value
to risk factors in intermediate risk populations [17]. The
value of performing a CCS in patients undergoing CTCA has
not been well investigated, and, because the CCS adds about
1e3 mSv to the total radiation dose, there is uncertainty
whether it should be performed in conjunction with CTCA.
Some investigators suggest that the CCS may be used as
a gatekeeper for CTCA because the specificity and accuracy
of CTCA may vary depending on the amount and location of
the coronary calcification [18]. In the absence of definitive
data that support the clinical utility of performing a CCS in
conjunction with CTCA, we recommend acquiring a CCS
only when specifically requested by the ordering physician.
This strategy has recently been tested in conjunction with the
implementation of other radiation doseereduction tech-
niques, which were shown to be associated with a successful
reduction in total radiation dose [8].
Several factors may affect radiation exposure and image
quality of CCS measurements, including the specifics of the
CT scan unit, exposure parameters (tube current and poten-
tial), and the prescribed protocol (type of electrocardio-
graphic [ECG] gating, detector configuration, section
thickness, pitch, and reconstruction algorithm), variations
caused by nonreproducible positioning of the coronary artery
between heart beats and motion artifact [19]. One parameter
that can directly influence the radiation dose of the CCS isthe type of ECG gating used (see below under ‘‘ECG
gating’’). Depending on the available CT scan unit, the CCS
can be performed by using prospective or retrospective ECG
gating. Most manufacturers recommend the utilisation of
prospective ECG gating, with sequential acquisitions rather
than retrospective ECG gating with helical techniques to
limit radiation exposure [20]. Alternatively, retrospective
ECG-gating facilitates selection of the most appropriate
cardiac phase to reconstruct the data set to avoid motion
artifacts and, therefore, to decrease variability in CCS
measurement [21]. Dose-modulation techniques also help to
decrease radiation exposure in retrospective ECG gating (see
below under ‘‘ECG gating’’) and may be used in CCS
protocols.
The lack of a standardized protocol for CCS acquisition
when using MDCT is one of the major limitations of this
technique, which can be associated with more than 10-fold
variation in radiation doses [22]. The constant evolution of
MDCT technology may help to decrease this variability and
the radiation exposure associated with a CCS measurement.
However, it is an additional barrier to the creation of
a uniform and universal protocol. Therefore, it is essential to
optimize CCS protocols to minimize the dose while main-
taining adequate image quality [22]. The specifics of the
available CT unit will determine the protocol to be used;
a few optimized protocols have been suggested for a limited
number of scanners [19].
Heart-Rate Control: Intravenous Medication
Some cardiac centers prefer using intravenous metoprolol
in aliquots of 2.5e5 mg as slow intravenous boluses to
a maximum of 15-20 mg titrated to the ECG tracing [13,23]
instead of an oral beta-blocker. There is a significantly faster
onset of action compared with the oral route, and the intrave-
nous preparation bypasses the need for hepatic metabolism,
achieving plasma concentrations of approximately twice that
seen with the oral route of administration [13]. However, the
intravenous preparation is significantly more expensive and
requires direct medical supervision. There has been no scien-
tific evaluation that compared the 2 preparations in terms of
image quality and radiation dose. Often in clinical practice,
oral metoprolol is used and additional intravenous metoprolol
is administered if required in the CT suite [24]. If the patient
has contraindications to beta-blockers, then alternative medi-
cation, such as a calcium channel blocker (diltiazem), can be
used. In every situation, contraindications to beta-blockers (or
to an alternative medication) must be respected to ensure a safe
administration. In dual-detector CT scanners (ie, dual-source
units), there is improved image quality with heart-rate control,
and the improved temporal resolution associated with this
generation of MDCTis capable of achieving diagnostic images
in patients with high heart rates of 120e140 bpm [16].
Nitroglycerin
Nitroglycerin causes coronary vasodilatation and was
initially used in conventional coronary angiography [25].
When administered immediately before initiating the CTCA,
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significant coronary dilation and improved intraluminal
contrast agent density of peripheral vessels, which results in
an increased number of assessable segments [26e28].
Therefore, in the absence of contraindications, all patients
should receive nitroglycerin to improve image quality. Our
practice is to administer 0.3 mg of sublingual nitroglycerin
immediately before the scan in all patients with no contra-
indications and a systolic blood pressure >100 mm Hg.
Contrast Injection Protocol
The magnitude of contrast enhancement for CTA depends
on a number of patient-related and injection-related factors,
including body weight and cardiac output, contrast medium
volume and concentration, injection rate, type of contrast
medium, and saline solution flush. The optimal degree of
contrast enhancement of the ascending aorta and coronary
arteries is suggested to be 300e350 HU (net contrast
enhancement of 250e300 HU) [29e31]. One of the most
important patient-related factors that affects the magnitude of
vascular contrast enhancement is body weight. Therefore, to
achieve a consistent and adequate degree of contrast
enhancement of the coronary arteries, the amount of
administered contrast medium should be adjusted according
to the patient’s body weight [32].
The most common methods used for estimating the time of
contrast material arrival in the anatomy of interest and,
therefore, for timing image acquisition, are the test-bolus and
the bolus-tracking techniques. In the test-bolus method,
a small volume of iodinated contrast media (20 mL or
15%e20% of the volume of the main bolus) is injected at the
same infusion rate that will be used for the CTCA, and
a reference image at the level of the anatomy of interest is
acquired by using low-dose exposure parameters, every 1e2
seconds to determine the time taken for the contrast media
bolus to reach the target anatomy. The advantages of this
method include an opportunity to test the integrity of the
vascular access before the main bolus injection and an
opportunity for the patient to experience the contrast injection
in preparation for the main bolus infusion. In contrast, the
bolus-tracking method involves the placement of a region of
interest (ROI) at the level of the target anatomy (ie, ascending
or proximal descending aorta) to monitor the arrival of the
main bolus during injection in real time, with the acquisition
of a low-dose reference image every 1e2 seconds at the same
level of the anatomy of interest. The operator can choose
between starting the acquisition automatically, with a pre-
defined trigger attenuation threshold, or manually. This
method is generally preferred over the timing-bolus technique
because of its efficiency and practicality [33e35].
Different protocols have been used in CTCA, and the
choice of a specific protocol will depend on several factors,
including the type of contrast media and contrast injector
available, the type of the MDCT unit, and the desire to
evaluate the right atrium or right ventricle. Recommenda-
tions have been published for 64-row MDCTCA [36]. New
developments in MDCT technology (eg, scanners with dual-energy capability, wide-area detector scanners, faster rotation
times, and faster scan times) require individual adaptations
with tailored protocols.
Exposure Parameters
As in conventional radiology, modifications in tube
current-time product (mAs) have a linear relationship to
radiation dose. Modifications in tube current-time product
can be performed by changing the tube current (mA) and/or
by changing the exposure time (seconds) to decrease or
eliminate radiation exposure in periods of the cardiac cycle
that will not be used to generate images.
Tube Current
Different strategies have been studied to optimize the tube
current in CTCA and include weight-based and noise-based
approaches. In the weight-based approach, the tube current is
selected according to the patient’s body weight or body mass
index (BMI) [37,38]. The use of a fixed tube current will likely
generate unnecessary overexposure in a considerable number of
patients. Tailoring the tube current to body weight (or BMI) is an
attempt to correct for different body shapes, optimizing radiation
exposure while maintaining image quality. In the noise-based
approach, an axial image through the heart is acquired before
contrast injection and an ROI is placed in the aorta to measure the
CTunits (hounsfield units) and its standard deviation, a surrogate
measure for image noise (the higher the standard deviation, the
higher the noise). This information can be used to adjust the tube
current accordingly, optimizing image quality and radiation dose
on an individual basis. Newer approaches, based on thoracic
shape or diameter, are under investigation and may become
a better alternative in the near future.
Tube Potential
The relationship between dose and tube potential is not
linear but exponential, with radiation exposure being
approximately proportional to the square of the tube voltage.
Decreasing the tube potential from 120 kVp to 100 kVp in
patients with normal body weight is associated with a 25%e
39% reduction in the average effective dose without
compromising image quality [39,40]. Therefore, the selec-
tion of tube potential should be adapted to BMI to avoid
overexposure in slim patients, reducing radiation dose while
maintaining adequate image quality [41].
ECG Gating
To acquire motion-free images of the coronary arteries,
each reconstructed image must correspond to the same point in
time of the cardiac cycle; this can be achieved by synchroni-
zation with the ECG (ECG gating). Two methods are currently
in use: retrospective and prospective ECG gating (Figure 1).
Retrospective ECG Gating. In retrospective ECG gating, the
x-ray beam is activated during the entire cardiac cycle and
images are retrospectively reconstructed in any desired phase
of the R-R interval. This type of gating offers the possibility of
selecting a different reconstruction interval after the images
Figure 1. (A) Retrospective electrocardiographic (ECG) gating. Exposure of the entire R-R interval allows maintenance of image quality during the entire
cardiac cycle at the expense of a high radiation dose. (B) Retrospective ECG gating with ECG-controlled tube-current modulation; full exposure full tube
current is maintained only during a prescribed window of the R-R interval (ie, 30%e90%), with reduction of the tube current (mAs) to 20% or less during the
remainder of the cardiac cycle. (C) Prospective ECG gating. Exposure is maintained only during a predefined window (phase window) of the R-R interval (ie,
30%e90%). (D) Prospective ECG gating with a narrow phase window. Exposure is maintained only during a very short window of the R-R interval (ie, 75%).
PW ¼ phase window.
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phase for reconstruction for each coronary vessel, depending
on the heart’s movement. The maintenance of exposure during
the entire cardiac cycle also allows for the construction of cine
images, which are used to assess ejection fraction, wall-motion
abnormalities, and valvular function. However, because the
patient is irradiated during the entire cardiac cycle, retro-
spective ECG gating is also associated with a high radiation
dose [42]. To minimize radiation exposure, the intensity of the
x-ray beam can be modulated during phases not likely to be
used for evaluation of coronary arteries (ECG-controlled tube
current modulation). Used in conjunction with retrospective
ECG gating, this method modulates the tube current during the
cardiac cycle to maintain full exposure only during a certain
window of the R-R interval, where the information will be used
to generate diagnostic images of the coronary arteries (typi-
cally in mid-diastole). In the remainder of the cardiac cycle, the
tube current is reduced to 20% or even less [43]. This approach
has been shown to significantly reduce the radiation dose and is
strongly recommended in the majority of cases. However, in
patients with an increased (>65 bpm) and irregular heart rate,
this method may not be appropriate, because the optimal phase
of the cardiac cycle for image reconstruction moves towards
the systolic period where the tube current is, with this method,
very low and, therefore, of insufficient quality for coronary
evaluation.
Prospective ECG Gating. In prospective ECG gating, expo-
sure can be limited to a specific period of the cardiac cycle,
from a certain time point after the R wave of the ECG (triggerdelay) until a second predefined time point in the cardiac cycle.
This period of the R-R interval when the x-ray tube is activated
is called the phase window (PW). Narrowing the PW decreases
the radiation dose but also decreases the number of phases of
the cardiac cycle available for image reconstruction. There-
fore, irregular and/or increased heart rates are not suitable for
prospective ECG gating with a narrow PW, because the
probability of acquiring only nondiagnostic images increases
[44]. Nonetheless, in patients with a regular and slow heart rate
(<65 bpm), prospective ECG gating with a narrow PW has
been shown to dramatically reduce the radiation dose in CTCA
while maintaining image quality comparable with retrospec-
tive ECG gating [45e47].
In prospective ECG gating, selection of an appropriate PW is
a crucial step, because, unlike retrospective ECG gating, only
a few phases of the cardiac cycle will be available for recon-
struction. It is well recognized that, with an increase in heart
rate, the optimal phase for image reconstruction moves from
diastole towards systole. Therefore, the selected PW must match
the optimal phase for image reconstruction according to the
patient’s heart rate [47]. Ideally, the heart rate of all patients
should be controlled to <65 bpm before proceeding to the
scanner table to avoid using wider PWs or retrospective ECG
gating, which are both associated with a higher radiation dose
than prospective ECG gating with a narrow PW [43,47,48].
Z-axis Coverage
Craniocaudal or Z-axis length is a major determinant of the
total radiation dose of a CT examination, because it directly
impinges upon the dose-length product. Limiting the Z-axis
Table 2
General recommendations for computed tomography coronary angiography
optimizationa
Step 1: Patient preparation
 Appropriate indication
 Adequate instructions
 Breath-holding practice (2  10 s)
 Medicationb
o Oral beta-blocker (metoprolol 75e150 mg or equivalent), to achieve
HR 60 bpm
 Right antecubital line, 18-gauge or larger
 CCS only if clinically indicated
Step 2: Data acquisition
 CCS: only if specifically requested
 Medicationb
o Intravenous beta-blocker (metoprolol 5e20 mg or equivalent)
o Sublingual nitroglycerin (0.3 mg) on the scanner table
 Contrast injection protocol adapted to body weight or body mass index
 Exposure parameters adapted to body weight or body mass indexc
o Tube potential (kVp)
o Tube current (mA)
 Prospective ECG gating if HR 65 bpm and regular
o Narrow phase window to expose only 10%e20% of the R-R
interval (ie, from 70%e80%) if HR 60 bpm
 Retrospective ECG gating
o ECG-controlled tube-current modulation in all patients unless atrial
fibrillation or frequent premature contractions are present
 Scan length based on CCS or low-dose scan ¼ [heart size þ 2 cm]
 Position the patient at the isocenter of the scanner and the heart at the
center of the display field of view
Step 3: After data acquisition
 Image reconstruction filters
o Medium smooth for coronary evaluation
o Sharp (or stent specific) if stent is present or highly calcified
coronaries
HR¼ heart rate; CCS¼ coronary calcium score; ECG¼ electrocardiography.
aThe value of some recommendations will depend on the characteristics
of the scanner (ie, temporal resolution, detector configuration, and total
acquisition time).
bContraindications must be respected to ensure a safe administration.
cSpecific recommendations depend on the characteristics of the scanner.
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[42]. Usually, the scout views are used to plan the craniocaudal
coverage to include the entire length of the coronary arteries in
the field of view (FOV). The coverage generally is set from
below the carina to the bottom of the heart. However, this
strategy may be inaccurate in identifying the origin of the
coronary arteries [49]. The use of the CCS images is a better
alternative and may be associated with radiation dose savings of
22%, on average, after performing the CTCA [50]. In this
method, the z-axis coverage should begin 1 cm above the origin
of the coronaries and end 1 cm below the posterior descending
coronary artery. If the CCS will not be performed, then a low
dose (<50 mA) prospectively ECG-gated acquisition similar to
the CCS could be performed as a localizer, with only a marginal
additional radiation dose. Alternatively, the acquisition of 2
breath-hold reference images, 1 at the expected start and 1 at the
expected end of the CTCA scan range, could also help to plan the
study with minimal radiation dose addition. However, because
this method only relies on 1 acquired image to define each end of
the scan range, it may be less accurate in defining the shortest
possible scan range than the aforementioned techniques.FOV
An important and sometimes forgotten step in reducing
the radiation dose and in optimizing image quality is the
proper positioning of the patient inside the gantry. Ideally,
the region of interest should be placed at the isocenter of the
gantry so that the x-ray beam that crosses this area in any
direction will have crossed the same amount of tissue when
assuming a cylindrical body shape. Because the shape of the
human thorax is not cylindrical, bow-tie filters were devel-
oped to attenuate the x-ray beam in the periphery, where
there is less tissue in comparison with the center, to maintain
a constant image noise. It is important to position the patient
in the center of the gantry to avoid variations in image noise
and an unnecessary increase in surface radiation dose
because of off-centering effects [51]. An appropriate scan
FOV (SFOV) should be selected to match the target anatomy
because the SFOV determines the shape of the bow-tie filter.
Selection of an inappropriate SFOV will lead to the intro-
duction of a wrong bow-tie filter, with a subsequent increase in
the radiation dose. Once the images of the anatomy included
within the SFOV are acquired, they will be reconstructed by
using a display FOV (DFOV) optimized for the examination.
Because, in the majority of patients, the heart is not in
the middle of the thorax, it will not appear in the center of the
DFOV. The technologist can position the heart within the
center of the DFOV in all 3 planes on the localizer radio-
graphs, but this adjustment cannot adequately replace proper
positioning of the patient at the isocenter of the gantry.Step 3: After Image Acquisition
Image Reconstruction Filters
CT images are reconstructed by using dedicated mathe-
matical algorithms known as reconstruction filters or filter
kernels. The properties of reconstruction filters are not subject
to standardization and can vary considerably among manu-
facturers. Nonetheless, labels such as smooth or sharp can be
used as indicators of the balance between spatial resolution and
image noise. Smooth kernels reduce noise at the expense of
spatial resolution, whereas sharper kernels improve spatial
resolution at the expense of increased noise. Because the
accuracy of a vascular diameter measurement [52] and the
attenuation of a coronary plaque vary with different recon-
struction filters [53], the selection of the most appropriate filter
kernel is crucial. In CTCA, the most frequently used recon-
struction filter for the evaluation of the coronary arteries is
a medium-smooth kernel. Shaper kernels should be used for
the evaluation of high-contrast structures, such as coronary
stents or highly calcified arteries. Dedicated, edge-enhancing
reconstruction filters have been developed for the evaluation of
stents and could be used if available [54,55].
Recommendations
A practical approach to minimize the radiation dose in
CTCA while maintaining image quality is summarized in
Table 2.
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The optimization of all aspects of CTCA, from patient
preparation to postprocessing techniques, should be the goal
of all examinations. The implementation of a protocol that
addresses most of these recommendations can effectively
reduce the radiation dose of CTCA while maintaining image
quality unchanged.
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42e9.Appendix A. Instruction Leaflet
What is a computed tomography (CT) coronary
angiography?
The computed tomography coronary angiography uses
x-rays, intravenous dye, and a computer technology to
visualize any narrowing or blockages in the heart arteries.
Preparation
On the day of your scheduled cardiac CT scan before coming
to the hospital:
 Take all your medications as you normally would, unless
your referring doctor advises you otherwise
 Bring the list of your medications
 Do not smoke or consume any drinks containing caffeine
after midnight before the procedure
 Do not eat anything for 4 hours before the test
Once you are in the cardiac preparation area:
 Change your clothes (from your waist up) for a patient gown
 Remove any jewelry on your neck and/or chest
 Your heart rate and blood pressure will be monitored by
a nurse
 You may need to have an electrocardiogram (ECG) done
 An intravenous line will be started in your arm
 You may be given medication, called a beta-blocker, and
you will be observed by a nurse until you are ready for
the CT scan (may take approximately 1 hour)
 From here you will be escorted to the CT scanning room
Female patients
If there is any possibility that you are pregnant, please
inform the nurse or technologist before having your test.
When you are in the CT scanning room, lying on the table,
the technologist will:
 Explain the procedure and confirm that you do not have
any contraindications for the scan
 Ask your permission to proceed
 Connect intravenous dye injector to your intravenous line
in your arm
 Place ECG leads onto your chest
 Practice breath hold with you. This is very important part
of the examination. You will be required to hold your
breath for about 5e15 seconds during the scan
Injection of dye
An iodine-based contrast will be used for the test. When the
dye is being injected, you may experience none, some, or all
of the following:
 A warm or hot feeling all over the body
 A metallic taste in your mouth
 Sensation that you may need to urinate
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are normal. There is a small risk of allergic reaction to this
dye. Your CT technologist will explain these to you before
starting of the scan.
Radiation exposure
The amount of x-ray radiation you may receive will
depend on your body size, how slow your heart rate is, and
the equipment used.
Once your test is done
 You will be escorted back to the cardiac preparation area
for observation (for approximately half an hour)
 After discharge, you may resume your normal activities,
unless you are advised otherwise
 You should drink 4e6 additional glasses of water per
day, for the next 2 days, unless your referring doctor
advises otherwise
 If you are diabetic and taking metformin, you should stop
taking it for 48 hours after the testPlease note:
You will need to be able to understand the information
given to you throughout the procedure.Appendix B. Common Products Containing Caffeine
Foods and beverages containing caffeine
a
Coffee
Decaffeinated coffee
Tea
Carbonated beverages, soft drinks (containing cola)
Cocoa products (ie, sweet chocolate, chocolate cake)
Energy drinks
Drinks containing guarana or yerba mate
Common medicines containing caffeine
b
Several over-the-counter preparations
Stimulants
Pain relievers
Cold remediesaSource: Health Canada (www.hc-sc.gc.ca/fn-an/securit/facts-faits/
caffeine-eng.php; accessed on October 15, 2009).
bBefore discontinuing any drug before an imaging study, the health care
provider responsible for the prescribed medication should be consulted.
